Mass General Brigham Incorporated

Location

Massachusetts

Founded

1994-02-13

Risk Signals

1496 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., General Medical and Surgical Hospitals), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about Mass General Brigham Incorporated

Live alerts from global media, monitored by Business Radar

Mass General Brigham backs virtual dementia care startup

2024-10-02 (beckershospitalreview.com)

Mass General Brigham backs virtual dementia care startup

Mass General Brigham invests in $23M funding round for dementia telehealth startup Rippl. Plans for multistate expansion with Alzheimer's Association a partner.

Read more
Health Systems Invest in Innovative Startups to Advance Care |

2022-10-18 (aha.org)

Health Systems Invest in Innovative Startups to Advance Care |

Global digital health funding for startups totaled $7.1 billion in Q2 according to a July report from CB Insights. Health systems are participating in funding innovative startups with the potential to improve various aspects of care delivery.

Read more
Mass General Brigham Reports Third Quarter 2022 Financial Results | Mass General Brigham

2022-08-12 (massgeneralbrigham.org)

Mass General Brigham Reports Third Quarter 2022 Financial Results | Mass General Brigham

Mass General Brigham Reports Third Quarter 2022 Financial Results Mass General Brigham Reports Third Quarter 2022 Financial Results Aug 12, 2022 share by email print article Health system remains committed to improving value, outcomes, and quality

Read more
Mass General Brigham lost $193 million at start of the year

2022-05-13 (bostonglobe.com)

Mass General Brigham lost $193 million at start of the year

The losses are due to high staffing costs, cancellations in elective procedures during the winter COVID-19 surge and other factors.

Read more
Mediar Therapeutics Adds New Investors As It Advances Anti-Fibrotic Treatments

2021-03-17 (businesswire.com)

Mediar Therapeutics Adds New Investors As It Advances Anti-Fibrotic Treatments

Mediar Therapeutics completes seed extension funding round with participation from Pfizer Ventures and Ono Venture Investment.

Read more

Never miss a headline about Mass General Brigham Incorporated

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages